Predicate |
Object |
contentType |
Journal Article|Review |
endingPage |
142 |
issn |
1540-8183 0896-4327 |
issueIdentifier |
2 |
pageRange |
129-142 |
publicationName |
Journal of Interventional Cardiology |
startingPage |
129 |
bibliographicCitation |
Talley JD. Clinical trials of glycoprotein IIb/IIIa inhibitors. J Interv Cardiol. 2001 Apr;14(2):129–42. doi: 10.1111/j.1540-8183.2001.tb00724.x. PMID: 12053294. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d7b08861b5b949e82427ba855d87f636 |
date |
200104 |
identifier |
https://pubmed.ncbi.nlm.nih.gov/12053294 https://doi.org/10.1111/j.1540-8183.2001.tb00724.x |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2162 https://portal.issn.org/resource/ISSN/0896-4327 https://portal.issn.org/resource/ISSN/1540-8183 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
Clinical Trials of Glycoprotein IIb/IIIa Inhibitors |
discusses |
http://id.nlm.nih.gov/mesh/M0028424 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D019039Q000037 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D016032 http://id.nlm.nih.gov/mesh/D000789Q000628 http://id.nlm.nih.gov/mesh/D009203Q000628 http://id.nlm.nih.gov/mesh/D015906 http://id.nlm.nih.gov/mesh/D006801 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7065 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6592 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6897 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9b21d1a174c364b6f99c6662d34d6034 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564 |